PERIODIC TABLES: OZEMPIC IS HERE TO STAY: EXPLORING THE HIGHS AND LOWS OF REVOLUTIONARY THERAPIES FOR DIABETES AND OBESITY
Webcast: Link
Sponsor(s): Duke Initiative for Science & Society
More than 70 million Americans live with obesity; 38 million have diagnosed diabetes and an additional 98 million have prediabetes. For the first time, people are flocking to their doctors for prescription of a new class of medications to treat metabolic disease. So how did a hormone found in lizard venom come to revolutionize diabetes and weight management? And how does my doctor choose which of these drugs is right for me?
With Klara R. Klein, MD, PhD, Assistant Professor of Medicine, Division of Endocrinology and Metabolism, University of North Carolina at Chapel Hill
Type: ENERGY, ETHICS, DIVERSITY/INCLUSION, ENGINEERING, HUMANITIES, SOCIAL SCIENCES, RESEARCH, and TECHNOLOGY
Contact: Madeline Liddicoat